APA (7th ed.) Citation

Yi, S., Kim, I., Hager, R., Strazzeri, M. M., Garrard, L., Matsubayashi, T., & Mehta, R. Food and Drug Administration Approval Summary: Odevixibat (Bylvay) for the Treatment of Pruritus With Progressive Familial Intrahepatic Cholestasis. Elsevier.

Chicago Style (17th ed.) Citation

Yi, Sojeong, Insook Kim, Rebecca Hager, Marian M. Strazzeri, Lili Garrard, Toru Matsubayashi, and Ruby Mehta. Food and Drug Administration Approval Summary: Odevixibat (Bylvay) for the Treatment of Pruritus With Progressive Familial Intrahepatic Cholestasis. Elsevier.

MLA (9th ed.) Citation

Yi, Sojeong, et al. Food and Drug Administration Approval Summary: Odevixibat (Bylvay) for the Treatment of Pruritus With Progressive Familial Intrahepatic Cholestasis. Elsevier.